Ccnd2-KO Mouse
一般名
Ccnd2-KO
製品ID
S-KO-01373
背景情報
C57BL/6JCya
系統ID
KOCMP-12444-Ccnd2-B6J-VA
状況
このマウス系統を論文で使用する場合は、「Ccnd2-KO Mouse（カタログ番号S-KO-01373）はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Ccnd2-KO
系統ID
KOCMP-12444-Ccnd2-B6J-VA
遺伝子名
製品ID
S-KO-01373
遺伝子別名
cD2, Vin1, Vin-1, 2600016F06Rik
遺伝子別名
C57BL/6JCya
NCBI ID
修正
Conventional knockout
染色体
Chr 6
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000000188
NCBIトランスクリプトID
NM_009829.3
ターゲット領域
Exon 1~2
有効領域の大きさ
~8.5 kb
遺伝子研究の概要
Ccnd2, also known as Cyclin D2, is a critical cell cycle regulator and a key member of the cyclin D2-CDK4 (DC) complex. It plays a significant role in the cell cycle, specifically in the G1/S transition, and is involved in various biological processes such as cell proliferation, development, and tissue repair [2].
In aCML patients, Ccnd2 mutations in codons 280 and 281 were found in two cases, which rapidly developed progressive characteristics, suggesting it could be a new marker of aggressive disease [1]. Ccnd2 variants in the proximal region were associated with microcephaly, symmetric short stature, and mild developmental delay, while distal variants cause brain overgrowth [2]. Overexpression of Ccnd2 in human induced pluripotent stem cell-derived cardiomyocytes enhanced their efficacy for myocardial repair in swine and mouse models of myocardial infarction, leading to increased cell engraftment, improved cardiac function, and reduced infarct size [3,5,6]. In thyroid carcinoma, Ccnd2 expression was significantly increased, and along with miR-206, could potentially be biomarkers for diagnosis [4]. In cyclin D1-mantle cell lymphoma, Ccnd2 translocations were identified in a subset of cases, hijacking immunoglobulin light-chain enhancers [7].
In conclusion, Ccnd2 is crucial for cell cycle regulation and has implications in multiple biological processes and diseases. Studies, including those using animal models like mice, have revealed its role in conditions such as aCML, microcephaly-related disorders, myocardial infarction repair, thyroid carcinoma diagnosis, and mantle cell lymphoma pathogenesis. These findings enhance our understanding of the biological functions of Ccnd2 and its potential as a biomarker or therapeutic target in various diseases.
References:
1. Iaquinta, Giovanni, Scalzulli, Emilia, Angeloni, Silvia, Grammatico, Paola, Breccia, Massimo. 2023. CCND2 mutations in atypical chronic myeloid leukemia: a report of two cases. In Leukemia & lymphoma, 64, 1730-1732. doi:10.1080/10428194.2023.2232495. https://pubmed.ncbi.nlm.nih.gov/37435984/
2. Pirozzi, Filomena, Lee, Benson, Horsley, Nicole, Sanchez-Lara, Pedro A, Mirzaa, Ghayda M. 2021. Proximal variants in CCND2 associated with microcephaly, short stature, and developmental delay: A case series and review of inverse brain growth phenotypes. In American journal of medical genetics. Part A, 185, 2719-2738. doi:10.1002/ajmg.a.62362. https://pubmed.ncbi.nlm.nih.gov/34087052/
3. Zhao, Meng, Nakada, Yuji, Wei, Yuhua, Walcott, Gregory P, Zhang, Jianyi. 2021. Cyclin D2 Overexpression Enhances the Efficacy of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Myocardial Repair in a Swine Model of Myocardial Infarction. In Circulation, 144, 210-228. doi:10.1161/CIRCULATIONAHA.120.049497. https://pubmed.ncbi.nlm.nih.gov/33951921/
4. Yuan, Shifa, Liu, Zhijun, Yu, Shanshan, Wang, Xiaolei, Shi, Jian. 2023. CCND2 and miR-206 as potential biomarkers in the clinical diagnosis of thyroid carcinoma by fine-needle aspiration cytology. In World journal of surgical oncology, 21, 22. doi:10.1186/s12957-023-02899-w. https://pubmed.ncbi.nlm.nih.gov/36694220/
5. Fan, Chengming, Fast, Vladimir G, Tang, Yawen, Zhu, Wuqiang, Zhang, Jianyi. 2019. Cardiomyocytes from CCND2-overexpressing human induced-pluripotent stem cells repopulate the myocardial scar in mice: A 6-month study. In Journal of molecular and cellular cardiology, 137, 25-33. doi:10.1016/j.yjmcc.2019.09.011. https://pubmed.ncbi.nlm.nih.gov/31629738/
6. Zhu, Wuqiang, Zhao, Meng, Mattapally, Saidulu, Chen, Sifeng, Zhang, Jianyi. 2017. CCND2 Overexpression Enhances the Regenerative Potency of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Remuscularization of Injured Ventricle. In Circulation research, 122, 88-96. doi:10.1161/CIRCRESAHA.117.311504. https://pubmed.ncbi.nlm.nih.gov/29018036/
7. Martín-Garcia, David, Navarro, Alba, Valdés-Mas, Rafael, Campo, Elias, Beà, Sílvia. 2018. CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1- mantle cell lymphoma. In Blood, 133, 940-951. doi:10.1182/blood-2018-07-862151. https://pubmed.ncbi.nlm.nih.gov/30538135/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。